Request Free Sample ×
ReportInfographic

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background
English
Chinese
French
Japanese
Korean
German
Spanish

Veterinary POC Diagnostic Market Trends

ID: MRFR/HC/8540-HCR
100 Pages
Rahul Gotadki
March 2026

Veterinary POC Diagnostic Market Research Report By Product Type (Immunoassays, Sampling Devices, Molecular Diagnostics, Hematology Analyzers), By Technology (Biochemical Analysis, Microbiology Testing, Genetic Testing), By Animal Type (Companion Animals, Livestock, Zoo Animals), By End User (Veterinary Clinics, Research Laboratories, Animal Hospitals) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth & Industry Forecast 2025 To 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Veterinary POC Diagnostic Market Infographic
Request Free Sample
Purchase Options
Compare License
Summary Table of Contents Segmentation Download PDF

Market Trends

Key Emerging Trends in the Veterinary POC Diagnostic Market

The veterinary point-of-care (POC) diagnostic market is witnessing significant growth, driven by the rising global trend of increased pet ownership. As more people bring pets into their homes, the demand for rapid and convenient diagnostic solutions at veterinary clinics and pet care facilities is on the rise. Technological development is molding market trends in veterinary PODs. The advent of portable and easily accessed diagnostic devices has streamlined quicker and efficient tests for different conditions in animals. These new developments contribute to better veterinary treatment and mobility in case of the sane people and vets. Increasing attention is paid to point of care testing of infectious diseases in the veterinary POC diagnostic market. Prompt and accurate diagnoses of diseases such as parvovirus, feline leukemia, and canine heartworm expedite timely medication initiation and prevent the transmission of infections between animals leading to improved health. The growing awareness of zoonotic diseases that can be transferred from animals to humans is impacting market dynamics. Veterinary point-of-care diagnostics significantly contribute to the prevention and control of zoonotic diseases and the health of both animals and humans caring for them. The veterinary POC diagnostic market has gained popularity globally, although, the growth in developing nations is expected to be prominent particularly because ofincreased interest by laboratories and producers. The rapidly growing role of veterinary medicine alongside an increase in disposable income were pushing the adoption of POC diagnostic tools in these areas which resulted in market expansion. An interesting trend in the field of veterinary POC diagnostics is AI and data analytics integration. The decision accuracy of the diagnosis is increased thanks to advanced algorithms in this way helping veterinarians create effective treatment plans according to individual animals. Among the preventive care that has gained popularity in the veterinary section, POC diagnostics are pivotal in the shift. Detection of conditions during routine testing enables early intervention before the condition progresses thereby contributing to the health and welfare of animals. The veterinary POC diagnostic market is adjusting to remote monitoring and telemedicine adoption for animals. Diagnostic instrumentation from POC for cancer detection including devices that support transmission of remote data enable veterinarians to monitor the health of animals remotely providing timely insights and reducing the need for regular visits. Animal diagnoses are becoming increasingly species specific. The veterinary POC diagnostic market is undergoing the development of focused tests and equipment for different type animals, fulfill species ranging from pet animals to livestock unique healthcare. Environmental testing for animal health is gaining prominence in the veterinary POC diagnostic market. Diagnostic tools are being employed to assess environmental factors that can impact animal health, such as water and soil quality. This trend reflects a holistic approach to veterinary care, considering both direct and indirect factors affecting animals.

Author
Author Profile
Rahul Gotadki
Research Manager

He holds an experience of about 9+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.

Get In Touch

Leave a Comment

FAQs

What is the projected market valuation of the Veterinary POC Diagnostic Market by 2035?

<p>The Veterinary POC Diagnostic Market is projected to reach a valuation of 5.627 USD Billion by 2035.</p>

What was the market valuation of the Veterinary POC Diagnostic Market in 2024?

<p>In 2024, the market valuation of the Veterinary POC Diagnostic Market was 2.468 USD Billion.</p>

What is the expected CAGR for the Veterinary POC Diagnostic Market during the forecast period 2025 - 2035?

<p>The expected CAGR for the Veterinary POC Diagnostic Market during the forecast period 2025 - 2035 is 7.78%.</p>

Which product type segment is projected to grow significantly in the Veterinary POC Diagnostic Market?

<p>The Immunoassays and Molecular Diagnostics segments are projected to grow significantly, with valuations expected to reach 1.7065 USD Billion by 2035.</p>

How do the market valuations for companion animals compare to livestock in the Veterinary POC Diagnostic Market?

<p>By 2035, the market valuation for companion animals is expected to reach 2.8 USD Billion, compared to 2.1 USD Billion for livestock.</p>

What are the key players in the Veterinary POC Diagnostic Market?

<p>Key players in the Veterinary POC Diagnostic Market include Idexx Laboratories, Zoetis, and Thermo Fisher Scientific, among others.</p>

What is the projected market size for veterinary clinics by 2035?

<p>The market size for veterinary clinics is projected to reach 1.7065 USD Billion by 2035.</p>

Which technology segment is expected to see the highest growth in the Veterinary POC Diagnostic Market?

<p>The Biochemical Analysis segment is expected to see substantial growth, with a projected valuation of 1.7065 USD Billion by 2035.</p>

What is the expected market size for animal hospitals in 2035?

<p>The expected market size for animal hospitals is projected to reach 2.765 USD Billion by 2035.</p>

How does the market for zoo animals compare to that of companion animals in terms of projected growth?

<p>The market for zoo animals is projected to grow to 0.727 USD Billion by 2035, which is significantly lower than the 2.8 USD Billion projected for companion animals.</p>

Market Summary

As per Market Research Future analysis, the Veterinary POC Diagnostic Market was estimated at 2.468 USD Billion in 2024. The Veterinary POC Diagnostic industry is projected to grow from 2.66 USD Billion in 2025 to 5.627 USD Billion by 2035, exhibiting a compound annual growth rate (CAGR) of 7.78% during the forecast period 2025 - 2035

Key Market Trends & Highlights

The Veterinary POC Diagnostic Market is experiencing robust growth driven by technological advancements and an increasing focus on preventive care.

  • North America remains the largest market for veterinary POC diagnostics, driven by high pet ownership rates and advanced healthcare infrastructure. The Asia-Pacific region is emerging as the fastest-growing market, fueled by rising disposable incomes and increasing awareness of animal health. Immunoassays dominate the market as the largest segment, while molecular diagnostics are rapidly gaining traction as the fastest-growing segment. Key market drivers include technological advancements in diagnostics and a rising demand for zoonotic disease testing, reflecting a shift towards preventive care.

Market Size & Forecast

2024 Market Size 2.468 (USD Billion)
2035 Market Size 5.627 (USD Billion)
CAGR (2025 - 2035) 7.78%
Largest Regional Market Share in 2024 North America

Major Players

<a href="https://www.idexx.com/en/veterinary/reference-laboratories/">Idexx Laboratories</a> (US), Zoetis (US), Thermo Fisher Scientific (US), Heska Corporation (US), <a href="https://www.neogen.com/en/categories/veterinary-diagnostics/?srsltid=AfmBOoqfL5Wcl-PJzAY-djBww9M9eo9ZqQxALGYSj-rPHXUdA4wQ2x-R">Neogen Corporation</a> (US), Virbac (FR), Boehringer Ingelheim (DE), Randox Laboratories (GB), EIKEN Chemical (JP)

Market Trends

The Veterinary POC Diagnostic Market is currently experiencing a notable transformation, driven by advancements in technology and an increasing emphasis on rapid diagnostics. This market encompasses a range of point-of-care testing solutions that facilitate immediate results for various veterinary conditions. The growing awareness of animal health and welfare, coupled with the rising demand for efficient diagnostic tools, appears to be propelling the market forward. Furthermore, the integration of innovative technologies, such as mobile applications and cloud-based data management, seems to enhance the accessibility and usability of these diagnostic devices. In addition, the Veterinary POC Diagnostic Market is likely to benefit from the increasing prevalence of zoonotic diseases and the need for timely interventions. Veterinary professionals are increasingly seeking tools that provide quick and accurate results, which may lead to improved treatment outcomes. The trend towards preventive care and routine health monitoring in pets and livestock is also influencing the market landscape. As stakeholders continue to prioritize animal health, the Veterinary POC Diagnostic Market is poised for sustained growth, reflecting a broader commitment to enhancing veterinary care and ensuring the well-being of animals across various settings.

Technological Advancements

The Veterinary POC Diagnostic Market is witnessing a surge in technological innovations, which are enhancing the capabilities of diagnostic tools. These advancements include the development of portable devices that offer rapid testing and results, thereby streamlining the diagnostic process. Such innovations are likely to improve the efficiency of veterinary practices and facilitate better decision-making.

Increased Focus on Preventive Care

There is a growing trend towards preventive care within the Veterinary POC Diagnostic Market, as veterinarians and pet owners alike recognize the importance of early detection of health issues. This shift is encouraging the adoption of diagnostic tools that enable routine health monitoring, ultimately leading to improved animal welfare and reduced healthcare costs.

Rising Demand for Zoonotic Disease Testing

The Veterinary POC Diagnostic Market is experiencing an increased demand for testing solutions related to zoonotic diseases. As awareness of the transmission of diseases from animals to humans rises, veterinary professionals are prioritizing diagnostics that can quickly identify potential health threats. This trend underscores the importance of timely interventions in safeguarding both animal and human health.

Veterinary POC Diagnostic Market Market Drivers

Regulatory Support and Standards

Regulatory support plays a crucial role in shaping the Veterinary POC Diagnostic Market. Governments and regulatory bodies are increasingly establishing standards and guidelines that facilitate the development and approval of veterinary diagnostic products. This support not only ensures the safety and efficacy of diagnostic tools but also encourages innovation within the industry. As regulatory frameworks become more favorable, manufacturers are likely to invest in research and development, leading to the introduction of new and improved diagnostic solutions. This regulatory environment is expected to positively influence the growth trajectory of the Veterinary POC Diagnostic Market.

Growing Pet Ownership and Spending

The Veterinary POC Diagnostic Market is significantly influenced by the growing trend of pet ownership and increased spending on pet care. As more households adopt pets, there is a corresponding rise in demand for veterinary services, including diagnostics. Pet owners are increasingly willing to invest in their pets' health, leading to higher expenditures on veterinary care. This trend is reflected in the projected growth of the veterinary diagnostics market, which is anticipated to reach USD 3.5 billion by 2026. The increasing focus on pet health and wellness is likely to drive the expansion of the Veterinary POC Diagnostic Market.

Increased Focus on Preventive Care

There is a notable shift towards preventive care within the Veterinary POC Diagnostic Market. Pet owners and veterinarians are increasingly recognizing the importance of early detection of diseases to ensure better health outcomes for animals. This trend is reflected in the rising demand for routine diagnostic tests, which are essential for monitoring the health of pets. The market is expected to grow as more veterinary practices adopt preventive care protocols, leading to an increase in the utilization of point-of-care diagnostics. This proactive approach not only enhances animal welfare but also contributes to the overall growth of the Veterinary POC Diagnostic Market.

Technological Advancements in Diagnostics

The Veterinary POC Diagnostic Market is experiencing a surge in technological advancements that enhance diagnostic capabilities. Innovations such as portable diagnostic devices and rapid testing kits are becoming increasingly prevalent. These technologies allow for immediate results, which is crucial in veterinary practices where timely decisions can significantly impact animal health. The market for veterinary diagnostics is projected to reach USD 3.5 billion by 2026, driven by these advancements. Furthermore, the integration of artificial intelligence and machine learning into diagnostic tools is expected to improve accuracy and efficiency, thereby fostering growth in the Veterinary POC Diagnostic Market.

Rising Demand for Zoonotic Disease Testing

The Veterinary POC Diagnostic Market is witnessing a rising demand for testing related to zoonotic diseases. As awareness of the transmission of diseases from animals to humans increases, there is a growing need for rapid and accurate diagnostic tools. This demand is particularly evident in regions where zoonotic diseases are prevalent, prompting veterinarians to utilize point-of-care diagnostics for timely identification and management. The market for zoonotic disease testing is projected to expand, driven by the need for effective surveillance and control measures. Consequently, this trend is likely to bolster the Veterinary POC Diagnostic Market.

Market Segment Insights

By Product Type: Immunoassays (Largest) vs. Molecular Diagnostics (Fastest-Growing)

In the Veterinary POC Diagnostic Market, the distribution of market share among product types reveals a pronounced dominance of <a href="https://www.marketresearchfuture.com/reports/immunoassay-market-5841">immunoassays</a>, which continue to capture the largest segment of the market. Their established usage in rapid disease detection and ease of integration into veterinary practice contribute to this leading position. Following immunoassays, <a href="https://www.marketresearchfuture.com/reports/molecular-diagnostics-market-1171">molecular diagnostics</a> emerge as a significant player, showcasing notable growth potential as diagnostic technologies evolve and practices seek more accurate pathogen identification.

Immunoassays (Dominant) vs. Molecular Diagnostics (Emerging)

Immunoassays stand as the dominant technology in the Veterinary POC Diagnostic Market, celebrated for their rapid results and reliability in diagnosing infectious diseases. The ease of use and minimal training required for operators make immunoassays a staple in veterinary clinics. In contrast, molecular diagnostics represent an emerging technology trend, gaining traction due to advancements in techniques such as PCR and next-generation sequencing. Though currently smaller in market share, molecular diagnostics are poised for accelerated growth, driven by the demand for precise and rapid testing solutions. As veterinary professionals increasingly adopt these technologies, the competitive landscape is bound to shift, highlighting the importance of both segments in shaping the future of veterinary diagnostics.

By Technology: Biochemical Analysis (Largest) vs. Microbiology Testing (Fastest-Growing)

In the Veterinary POC Diagnostic Market, Biochemical Analysis holds the largest share owing to its widespread application in routine diagnostics for various conditions in animals. This segment is essential for evaluating metabolic disorders, organ function, and overall health, making it a foundational aspect of veterinary diagnostics. On the other hand, Microbiology Testing is identified as the fastest-growing segment in the market. The increasing prevalence of infectious diseases and the growing demand for rapid point-of-care testing methods have propelled its growth. The need for timely diagnostics to make informed treatment decisions is a significant driver for this segment's expansion.

Technology: Biochemical Analysis (Dominant) vs. Microbiology Testing (Emerging)

Biochemical Analysis stands as the dominant technology in the Veterinary POC Diagnostic Market, characterized by its ability to provide critical information on animal health rapidly. It encompasses various assays that monitor crucial biochemical parameters like glucose, protein, and electrolyte levels, which are foundational for timely veterinary care. In contrast, Microbiology Testing, while emerging, plays a crucial role in diagnosing infections and guiding treatment protocols against pathogens. Its rapid growth is driven by advancements in testing technologies and increasing awareness of infectious diseases in animals, making it essential for ensuring the health and well-being of veterinary patients.

By Animal Type: Companion Animals (Largest) vs. Livestock (Fastest-Growing)

The Veterinary POC Diagnostic Market is predominantly driven by the Companion Animals segment, which holds the largest share. This segment's growth is attributed to the increasing pet ownership rates and the rising awareness among pet owners about the importance of regular health check-ups. Meanwhile, the Livestock segment is gaining traction as the fastest-growing category, fueled by the demand for advanced diagnostic solutions in agricultural practices and the need for optimizing livestock health management.

Companion Animals (Dominant) vs. Livestock (Emerging)

The <a href="https://www.marketresearchfuture.com/reports/companion-animal-healthcare-market-1168">Companion Animals</a> segment is the dominant player in the Veterinary POC Diagnostic Market, characterized by a broad range of diagnostic tests designed for pets such as dogs and cats. This segment is supported by a growing trend in pet humanization, leading to increased spending on pet healthcare and diagnostics. On the other hand, the Livestock segment is emerging as a significant focus due to the increasing need for monitoring health in cattle, pigs, and poultry. The demand for rapid and accurate diagnostics in livestock farming is driven by the necessity to enhance productivity and manage diseases effectively, making it a pivotal area of growth within the market.

By End User: Veterinary Clinics (Largest) vs. Animal Hospitals (Fastest-Growing)

The Veterinary POC Diagnostic Market is witnessing a strategic distribution of market share across its primary end-user segments, which include Veterinary Clinics, Research Laboratories, and Animal Hospitals. Veterinary Clinics represent the largest share, primarily due to the higher frequency of tests and diagnostics performed within these facilities. In comparison, Research Laboratories are crucial for innovation and advancements, but they account for a smaller portion of the market, as they are not as widely utilized as veterinary clinics and animal hospitals. Animal Hospitals are emerging as the fastest-growing segment within this market, driven by an increasing demand for immediate diagnostic tests and the rising need for urgent care. The growing pet ownership and heightened awareness regarding animal health are key factors propelling this trend. Furthermore, advancements in POC diagnostic technologies are enhancing the capabilities of animal hospitals, enabling them to provide rapid and accurate testing, thereby supporting their expansion in the market.

Veterinary Clinics (Dominant) vs. Research Laboratories (Emerging)

Veterinary Clinics hold a dominant position in the Veterinary POC Diagnostic Market, primarily due to their extensive daily interactions with pet owners and the continuous requirement for diagnostic testing. They typically employ a variety of point-of-care devices to efficiently diagnose common ailments, thus promoting quicker treatment and improving patient outcomes. On the other hand, Research Laboratories, while considered an emerging segment, play a vital role in the development and validation of new diagnostic tools and technologies. They focus on innovative research, which ultimately aids in advancing the capabilities of veterinary diagnostics. As these laboratories evolve, they are increasingly becoming influential in determining future market trends, especially in terms of introducing cutting-edge diagnostic solutions.

Get more detailed insights about Veterinary POC Diagnostic Market Research Report - Global Forecast till 2035

Regional Insights

The Veterinary POC Diagnostic Market revenue showcases a clear regional layout, with North America holding a prominent position, recording a value of 1.1 USD Billion in 2023 and projected to reach 2.2 USD Billion by 2032. This dominance is primarily driven by advanced veterinary infrastructure and heightened awareness regarding animal health. Europe follows, exhibiting a significant valuation of 0.8 USD Billion in 2023, expected to attain 1.7 USD Billion by 2032, highlighting strong veterinary practices and increasing pet ownership.

The APAC region, while smaller, demonstrates potential with a market value of 0.25 USD Billion in 2023, anticipated to expand to 0.55 USD Billion by 2032, as emerging economies invest more in veterinary care. South America and MEA exhibit smaller shares, with valuations of 0.07 USD Billion each in 2023, growing to 0.12 USD Billion and 0.13 USD Billion, respectively, by 2032. These regions face challenges in veterinary services but present opportunities for growth driven by increased animal husbandry practices and awareness.

Overall, the Veterinary POC Diagnostic Market segmentation reveals diverse contributions from each region, underscoring varied growth dynamics and potential across the landscape.

Key Players and Competitive Insights

The Veterinary Point-of-Care (POC) Diagnostic Market is rapidly evolving, fueled by the increasing demand for rapid, accurate diagnostic solutions that facilitate timely decision-making in veterinary practices. This dynamic market encompasses various diagnostic tests and devices specifically designed to provide immediate results for veterinary professionals. The competitive landscape is characterized by a mix of established players and innovative newcomers, all striving to enhance their product offerings through technological advancements and expanding their market presence. Factors such as the rising prevalence of zoonotic diseases, growing pet ownership, and the increasing need for preventative healthcare in animals are propelling the market forward. Companies are focusing on strategic collaborations, mergers, and acquisitions to leverage their strengths and expand their footprint in emerging markets, thereby offering enhanced diagnostic solutions tailored to veterinarians' needs. Randox Laboratories has established itself as a leading player in the Veterinary POC Diagnostic Market, primarily due to its commitment to innovation and quality. The company offers a diverse portfolio of diagnostic solutions, including advanced testing platforms that cater specifically to veterinary practices. Randox Laboratories' strengths lie in its ability to provide rapid, reliable results across a wide range of veterinary conditions. Furthermore, the company has invested significantly in research and development, allowing it to stay ahead of industry trends and meet the evolving needs of its customers. With a strong emphasis on customer support and training, Randox Laboratories has built a solid reputation among veterinary professionals, enhancing its competitive edge and market presence. Neogen Corporation is another prominent player in the Veterinary POC Diagnostic Market, recognized for its dedication to providing effective diagnostic solutions for animal health. Known for its strong focus on food and animal safety, Neogen Corporation offers a range of innovative products tailored to the veterinary sector. The company has successfully developed and marketed POC diagnostic tests that are easy to use and deliver rapid results, making them highly preferable for veterinarians in various practice settings. Neogen Corporation's strengths are rooted in its broad distribution network and its ability to adapt to the ever-changing demands of the veterinary market. By leveraging its extensive research capabilities and commitment to quality, Neogen Corporation continues to solidify its presence and influence in the veterinary diagnostics landscape, making it a key player in the competitive environment of the Veterinary POC Diagnostic Market.

Key Companies in the Veterinary POC Diagnostic Market include

Industry Developments

  • Q2 2024: IDEXX Launches ProCyte One Hematology Analyzer for Veterinary Clinics IDEXX Laboratories announced the commercial launch of the ProCyte One Hematology Analyzer, a new point-of-care device designed to deliver rapid and accurate blood analysis for veterinary practices.
  • Q2 2024: Zoetis Receives CE Mark for Vetscan Imagyst Rapid Diagnostic Platform in Europe Zoetis announced it has received CE Mark approval for its Vetscan Imagyst platform, enabling the rapid deployment of its AI-powered point-of-care diagnostic solution for veterinary clinics across the European Union.
  • Q3 2024: Heska Expands Global Footprint with New Diagnostic Manufacturing Facility in Germany Heska Corporation opened a new manufacturing facility in Germany dedicated to the production of advanced point-of-care diagnostic devices for veterinary use, aiming to meet growing demand in the EMEA region.
  • Q1 2024: Antech Diagnostics Acquires UK-based POC Vet Diagnostics Startup Antech Diagnostics, a Mars Petcare company, announced the acquisition of a UK-based startup specializing in rapid point-of-care diagnostic tests for companion animals, strengthening its European market presence.
  • Q2 2024: Zoetis Announces Strategic Partnership with Mindray for Veterinary POC Devices Zoetis entered into a strategic partnership with Mindray to co-develop and distribute new point-of-care diagnostic devices for veterinary clinics, targeting both North American and Asia-Pacific markets.
  • Q2 2024: IDEXX Laboratories Appoints New Chief Technology Officer to Lead Diagnostic Innovation IDEXX Laboratories named Dr. Emily Chen as Chief Technology Officer, tasking her with accelerating the development of next-generation point-of-care diagnostic solutions for the veterinary sector.
  • Q3 2024: Zoetis Launches Vetscan Flex Rapid Test for Canine Parvovirus Zoetis introduced the Vetscan Flex Rapid Test, a new point-of-care diagnostic kit for the detection of canine parvovirus, expanding its suite of rapid veterinary diagnostics.
  • Q1 2025: IDEXX Receives FDA Clearance for SNAP Heartworm RT Test for Dogs IDEXX Laboratories announced it has received FDA clearance for its SNAP Heartworm RT Test, a rapid point-of-care diagnostic for canine heartworm disease, enabling broader clinical adoption in the U.S.
  • Q2 2025: Heska Secures Multi-Year Contract with Major U.S. Veterinary Chain for POC Diagnostics Heska Corporation signed a multi-year supply agreement with a leading U.S. veterinary clinic chain to provide point-of-care diagnostic equipment and consumables.
  • Q2 2025: Zoetis Launches Vetscan Imagyst Fecal Egg Count Test in Australia Zoetis expanded its Vetscan Imagyst platform with the launch of a new Fecal Egg Count Test for livestock in Australia, providing rapid, on-site parasite diagnostics for veterinarians and farmers.
  • Q3 2025: IDEXX Laboratories Acquires AI Diagnostics Startup to Enhance POC Offerings IDEXX Laboratories acquired a U.S.-based artificial intelligence diagnostics startup, aiming to integrate advanced AI capabilities into its point-of-care veterinary diagnostic platforms.
  • Q1 2025: FUJIFILM Europe Launches VETSCAN VUE Analyzer for Veterinary Clinics FUJIFILM Europe announced the launch of the VETSCAN VUE Analyzer, a new point-of-care diagnostic device designed for rapid in-clinic testing of multiple animal diseases.

Future Outlook

Veterinary POC Diagnostic Market Future Outlook

The Veterinary POC Diagnostic Market is projected to grow at a 7.78% CAGR from 2025 to 2035, driven by technological advancements, increasing pet ownership, and demand for rapid diagnostics.

New opportunities lie in:

  • <p>Development of portable diagnostic devices for remote veterinary practices. Integration of AI-driven analytics for enhanced diagnostic accuracy. Expansion of telemedicine platforms for real-time diagnostic consultations.</p>

By 2035, the market is expected to be robust, reflecting substantial growth and innovation.

Market Segmentation

Veterinary POC Diagnostic Market End User Outlook

  • Veterinary Clinics
  • Research Laboratories
  • Animal Hospitals

Veterinary POC Diagnostic Market Technology Outlook

  • Biochemical Analysis
  • Microbiology Testing
  • Genetic Testing

Veterinary POC Diagnostic Market Animal Type Outlook

  • Companion Animals
  • Livestock
  • Zoo Animals

Veterinary POC Diagnostic Market Product Type Outlook

  • Immunoassays
  • Sampling Devices
  • Molecular Diagnostics
  • Hematology Analyzers

Report Scope

MARKET SIZE 2024 2.468(USD Billion)
MARKET SIZE 2025 2.66(USD Billion)
MARKET SIZE 2035 5.627(USD Billion)
COMPOUND ANNUAL GROWTH RATE (CAGR) 7.78% (2025 - 2035)
REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR 2024
Market Forecast Period 2025 - 2035
Historical Data 2019 - 2024
Market Forecast Units USD Billion
Key Companies Profiled Idexx Laboratories (US), Zoetis (US), Thermo Fisher Scientific (US), Heska Corporation (US), Neogen Corporation (US), Virbac (FR), Boehringer Ingelheim (DE), Randox Laboratories (GB), EIKEN Chemical (JP)
Segments Covered Product Type, Technology, Animal Type, End User, Regional
Key Market Opportunities Integration of advanced technologies enhances rapid diagnostics in the Veterinary POC Diagnostic Market.
Key Market Dynamics Rising demand for rapid diagnostics drives innovation and competition in the Veterinary Point-of-Care Diagnostic Market.
Countries Covered North America, Europe, APAC, South America, MEA

FAQs

What is the projected market valuation of the Veterinary POC Diagnostic Market by 2035?

<p>The Veterinary POC Diagnostic Market is projected to reach a valuation of 5.627 USD Billion by 2035.</p>

What was the market valuation of the Veterinary POC Diagnostic Market in 2024?

<p>In 2024, the market valuation of the Veterinary POC Diagnostic Market was 2.468 USD Billion.</p>

What is the expected CAGR for the Veterinary POC Diagnostic Market during the forecast period 2025 - 2035?

<p>The expected CAGR for the Veterinary POC Diagnostic Market during the forecast period 2025 - 2035 is 7.78%.</p>

Which product type segment is projected to grow significantly in the Veterinary POC Diagnostic Market?

<p>The Immunoassays and Molecular Diagnostics segments are projected to grow significantly, with valuations expected to reach 1.7065 USD Billion by 2035.</p>

How do the market valuations for companion animals compare to livestock in the Veterinary POC Diagnostic Market?

<p>By 2035, the market valuation for companion animals is expected to reach 2.8 USD Billion, compared to 2.1 USD Billion for livestock.</p>

What are the key players in the Veterinary POC Diagnostic Market?

<p>Key players in the Veterinary POC Diagnostic Market include Idexx Laboratories, Zoetis, and Thermo Fisher Scientific, among others.</p>

What is the projected market size for veterinary clinics by 2035?

<p>The market size for veterinary clinics is projected to reach 1.7065 USD Billion by 2035.</p>

Which technology segment is expected to see the highest growth in the Veterinary POC Diagnostic Market?

<p>The Biochemical Analysis segment is expected to see substantial growth, with a projected valuation of 1.7065 USD Billion by 2035.</p>

What is the expected market size for animal hospitals in 2035?

<p>The expected market size for animal hospitals is projected to reach 2.765 USD Billion by 2035.</p>

How does the market for zoo animals compare to that of companion animals in terms of projected growth?

<p>The market for zoo animals is projected to grow to 0.727 USD Billion by 2035, which is significantly lower than the 2.8 USD Billion projected for companion animals.</p>

  1. SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. | 1.1 EXECUTIVE SUMMARY
    2. | | 1.1.1 Market Overview
    3. | | 1.1.2 Key Findings
    4. | | 1.1.3 Market Segmentation
    5. | | 1.1.4 Competitive Landscape
    6. | | 1.1.5 Challenges and Opportunities
    7. | | 1.1.6 Future Outlook
  2. SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. | 2.1 MARKET INTRODUCTION
    2. | | 2.1.1 Definition
    3. | | 2.1.2 Scope of the study
    4. | | | 2.1.2.1 Research Objective
    5. | | | 2.1.2.2 Assumption
    6. | | | 2.1.2.3 Limitations
    7. | 2.2 RESEARCH METHODOLOGY
    8. | | 2.2.1 Overview
    9. | | 2.2.2 Data Mining
    10. | | 2.2.3 Secondary Research
    11. | | 2.2.4 Primary Research
    12. | | | 2.2.4.1 Primary Interviews and Information Gathering Process
    13. | | | 2.2.4.2 Breakdown of Primary Respondents
    14. | | 2.2.5 Forecasting Model
    15. | | 2.2.6 Market Size Estimation
    16. | | | 2.2.6.1 Bottom-Up Approach
    17. | | | 2.2.6.2 Top-Down Approach
    18. | | 2.2.7 Data Triangulation
    19. | | 2.2.8 Validation
  3. SECTION III: QUALITATIVE ANALYSIS
    1. | 3.1 MARKET DYNAMICS
    2. | | 3.1.1 Overview
    3. | | 3.1.2 Drivers
    4. | | 3.1.3 Restraints
    5. | | 3.1.4 Opportunities
    6. | 3.2 MARKET FACTOR ANALYSIS
    7. | | 3.2.1 Value chain Analysis
    8. | | 3.2.2 Porter's Five Forces Analysis
    9. | | | 3.2.2.1 Bargaining Power of Suppliers
    10. | | | 3.2.2.2 Bargaining Power of Buyers
    11. | | | 3.2.2.3 Threat of New Entrants
    12. | | | 3.2.2.4 Threat of Substitutes
    13. | | | 3.2.2.5 Intensity of Rivalry
    14. | | 3.2.3 COVID-19 Impact Analysis
    15. | | | 3.2.3.1 Market Impact Analysis
    16. | | | 3.2.3.2 Regional Impact
    17. | | | 3.2.3.3 Opportunity and Threat Analysis
  4. SECTION IV: QUANTITATIVE ANALYSIS
    1. | 4.1 Healthcare, BY Product Type (USD Billion)
    2. | | 4.1.1 Immunoassays
    3. | | 4.1.2 Sampling Devices
    4. | | 4.1.3 Molecular Diagnostics
    5. | | 4.1.4 Hematology Analyzers
    6. | 4.2 Healthcare, BY Technology (USD Billion)
    7. | | 4.2.1 Biochemical Analysis
    8. | | 4.2.2 Microbiology Testing
    9. | | 4.2.3 Genetic Testing
    10. | 4.3 Healthcare, BY Animal Type (USD Billion)
    11. | | 4.3.1 Companion Animals
    12. | | 4.3.2 Livestock
    13. | | 4.3.3 Zoo Animals
    14. | 4.4 Healthcare, BY End User (USD Billion)
    15. | | 4.4.1 Veterinary Clinics
    16. | | 4.4.2 Research Laboratories
    17. | | 4.4.3 Animal Hospitals
    18. | 4.5 Healthcare, BY Region (USD Billion)
    19. | | 4.5.1 North America
    20. | | | 4.5.1.1 US
    21. | | | 4.5.1.2 Canada
    22. | | 4.5.2 Europe
    23. | | | 4.5.2.1 Germany
    24. | | | 4.5.2.2 UK
    25. | | | 4.5.2.3 France
    26. | | | 4.5.2.4 Russia
    27. | | | 4.5.2.5 Italy
    28. | | | 4.5.2.6 Spain
    29. | | | 4.5.2.7 Rest of Europe
    30. | | 4.5.3 APAC
    31. | | | 4.5.3.1 China
    32. | | | 4.5.3.2 India
    33. | | | 4.5.3.3 Japan
    34. | | | 4.5.3.4 South Korea
    35. | | | 4.5.3.5 Malaysia
    36. | | | 4.5.3.6 Thailand
    37. | | | 4.5.3.7 Indonesia
    38. | | | 4.5.3.8 Rest of APAC
    39. | | 4.5.4 South America
    40. | | | 4.5.4.1 Brazil
    41. | | | 4.5.4.2 Mexico
    42. | | | 4.5.4.3 Argentina
    43. | | | 4.5.4.4 Rest of South America
    44. | | 4.5.5 MEA
    45. | | | 4.5.5.1 GCC Countries
    46. | | | 4.5.5.2 South Africa
    47. | | | 4.5.5.3 Rest of MEA
  5. SECTION V: COMPETITIVE ANALYSIS
    1. | 5.1 Competitive Landscape
    2. | | 5.1.1 Overview
    3. | | 5.1.2 Competitive Analysis
    4. | | 5.1.3 Market share Analysis
    5. | | 5.1.4 Major Growth Strategy in the Healthcare
    6. | | 5.1.5 Competitive Benchmarking
    7. | | 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
    8. | | 5.1.7 Key developments and growth strategies
    9. | | | 5.1.7.1 New Product Launch/Service Deployment
    10. | | | 5.1.7.2 Merger & Acquisitions
    11. | | | 5.1.7.3 Joint Ventures
    12. | | 5.1.8 Major Players Financial Matrix
    13. | | | 5.1.8.1 Sales and Operating Income
    14. | | | 5.1.8.2 Major Players R&D Expenditure. 2023
    15. | 5.2 Company Profiles
    16. | | 5.2.1 Idexx Laboratories (US)
    17. | | | 5.2.1.1 Financial Overview
    18. | | | 5.2.1.2 Products Offered
    19. | | | 5.2.1.3 Key Developments
    20. | | | 5.2.1.4 SWOT Analysis
    21. | | | 5.2.1.5 Key Strategies
    22. | | 5.2.2 Zoetis (US)
    23. | | | 5.2.2.1 Financial Overview
    24. | | | 5.2.2.2 Products Offered
    25. | | | 5.2.2.3 Key Developments
    26. | | | 5.2.2.4 SWOT Analysis
    27. | | | 5.2.2.5 Key Strategies
    28. | | 5.2.3 Thermo Fisher Scientific (US)
    29. | | | 5.2.3.1 Financial Overview
    30. | | | 5.2.3.2 Products Offered
    31. | | | 5.2.3.3 Key Developments
    32. | | | 5.2.3.4 SWOT Analysis
    33. | | | 5.2.3.5 Key Strategies
    34. | | 5.2.4 Heska Corporation (US)
    35. | | | 5.2.4.1 Financial Overview
    36. | | | 5.2.4.2 Products Offered
    37. | | | 5.2.4.3 Key Developments
    38. | | | 5.2.4.4 SWOT Analysis
    39. | | | 5.2.4.5 Key Strategies
    40. | | 5.2.5 Neogen Corporation (US)
    41. | | | 5.2.5.1 Financial Overview
    42. | | | 5.2.5.2 Products Offered
    43. | | | 5.2.5.3 Key Developments
    44. | | | 5.2.5.4 SWOT Analysis
    45. | | | 5.2.5.5 Key Strategies
    46. | | 5.2.6 Virbac (FR)
    47. | | | 5.2.6.1 Financial Overview
    48. | | | 5.2.6.2 Products Offered
    49. | | | 5.2.6.3 Key Developments
    50. | | | 5.2.6.4 SWOT Analysis
    51. | | | 5.2.6.5 Key Strategies
    52. | | 5.2.7 Boehringer Ingelheim (DE)
    53. | | | 5.2.7.1 Financial Overview
    54. | | | 5.2.7.2 Products Offered
    55. | | | 5.2.7.3 Key Developments
    56. | | | 5.2.7.4 SWOT Analysis
    57. | | | 5.2.7.5 Key Strategies
    58. | | 5.2.8 Randox Laboratories (GB)
    59. | | | 5.2.8.1 Financial Overview
    60. | | | 5.2.8.2 Products Offered
    61. | | | 5.2.8.3 Key Developments
    62. | | | 5.2.8.4 SWOT Analysis
    63. | | | 5.2.8.5 Key Strategies
    64. | | 5.2.9 EIKEN Chemical (JP)
    65. | | | 5.2.9.1 Financial Overview
    66. | | | 5.2.9.2 Products Offered
    67. | | | 5.2.9.3 Key Developments
    68. | | | 5.2.9.4 SWOT Analysis
    69. | | | 5.2.9.5 Key Strategies
    70. | 5.3 Appendix
    71. | | 5.3.1 References
    72. | | 5.3.2 Related Reports
  6. LIST OF FIGURES
    1. | 6.1 MARKET SYNOPSIS
    2. | 6.2 NORTH AMERICA MARKET ANALYSIS
    3. | 6.3 US MARKET ANALYSIS BY PRODUCT TYPE
    4. | 6.4 US MARKET ANALYSIS BY TECHNOLOGY
    5. | 6.5 US MARKET ANALYSIS BY ANIMAL TYPE
    6. | 6.6 US MARKET ANALYSIS BY END USER
    7. | 6.7 CANADA MARKET ANALYSIS BY PRODUCT TYPE
    8. | 6.8 CANADA MARKET ANALYSIS BY TECHNOLOGY
    9. | 6.9 CANADA MARKET ANALYSIS BY ANIMAL TYPE
    10. | 6.10 CANADA MARKET ANALYSIS BY END USER
    11. | 6.11 EUROPE MARKET ANALYSIS
    12. | 6.12 GERMANY MARKET ANALYSIS BY PRODUCT TYPE
    13. | 6.13 GERMANY MARKET ANALYSIS BY TECHNOLOGY
    14. | 6.14 GERMANY MARKET ANALYSIS BY ANIMAL TYPE
    15. | 6.15 GERMANY MARKET ANALYSIS BY END USER
    16. | 6.16 UK MARKET ANALYSIS BY PRODUCT TYPE
    17. | 6.17 UK MARKET ANALYSIS BY TECHNOLOGY
    18. | 6.18 UK MARKET ANALYSIS BY ANIMAL TYPE
    19. | 6.19 UK MARKET ANALYSIS BY END USER
    20. | 6.20 FRANCE MARKET ANALYSIS BY PRODUCT TYPE
    21. | 6.21 FRANCE MARKET ANALYSIS BY TECHNOLOGY
    22. | 6.22 FRANCE MARKET ANALYSIS BY ANIMAL TYPE
    23. | 6.23 FRANCE MARKET ANALYSIS BY END USER
    24. | 6.24 RUSSIA MARKET ANALYSIS BY PRODUCT TYPE
    25. | 6.25 RUSSIA MARKET ANALYSIS BY TECHNOLOGY
    26. | 6.26 RUSSIA MARKET ANALYSIS BY ANIMAL TYPE
    27. | 6.27 RUSSIA MARKET ANALYSIS BY END USER
    28. | 6.28 ITALY MARKET ANALYSIS BY PRODUCT TYPE
    29. | 6.29 ITALY MARKET ANALYSIS BY TECHNOLOGY
    30. | 6.30 ITALY MARKET ANALYSIS BY ANIMAL TYPE
    31. | 6.31 ITALY MARKET ANALYSIS BY END USER
    32. | 6.32 SPAIN MARKET ANALYSIS BY PRODUCT TYPE
    33. | 6.33 SPAIN MARKET ANALYSIS BY TECHNOLOGY
    34. | 6.34 SPAIN MARKET ANALYSIS BY ANIMAL TYPE
    35. | 6.35 SPAIN MARKET ANALYSIS BY END USER
    36. | 6.36 REST OF EUROPE MARKET ANALYSIS BY PRODUCT TYPE
    37. | 6.37 REST OF EUROPE MARKET ANALYSIS BY TECHNOLOGY
    38. | 6.38 REST OF EUROPE MARKET ANALYSIS BY ANIMAL TYPE
    39. | 6.39 REST OF EUROPE MARKET ANALYSIS BY END USER
    40. | 6.40 APAC MARKET ANALYSIS
    41. | 6.41 CHINA MARKET ANALYSIS BY PRODUCT TYPE
    42. | 6.42 CHINA MARKET ANALYSIS BY TECHNOLOGY
    43. | 6.43 CHINA MARKET ANALYSIS BY ANIMAL TYPE
    44. | 6.44 CHINA MARKET ANALYSIS BY END USER
    45. | 6.45 INDIA MARKET ANALYSIS BY PRODUCT TYPE
    46. | 6.46 INDIA MARKET ANALYSIS BY TECHNOLOGY
    47. | 6.47 INDIA MARKET ANALYSIS BY ANIMAL TYPE
    48. | 6.48 INDIA MARKET ANALYSIS BY END USER
    49. | 6.49 JAPAN MARKET ANALYSIS BY PRODUCT TYPE
    50. | 6.50 JAPAN MARKET ANALYSIS BY TECHNOLOGY
    51. | 6.51 JAPAN MARKET ANALYSIS BY ANIMAL TYPE
    52. | 6.52 JAPAN MARKET ANALYSIS BY END USER
    53. | 6.53 SOUTH KOREA MARKET ANALYSIS BY PRODUCT TYPE
    54. | 6.54 SOUTH KOREA MARKET ANALYSIS BY TECHNOLOGY
    55. | 6.55 SOUTH KOREA MARKET ANALYSIS BY ANIMAL TYPE
    56. | 6.56 SOUTH KOREA MARKET ANALYSIS BY END USER
    57. | 6.57 MALAYSIA MARKET ANALYSIS BY PRODUCT TYPE
    58. | 6.58 MALAYSIA MARKET ANALYSIS BY TECHNOLOGY
    59. | 6.59 MALAYSIA MARKET ANALYSIS BY ANIMAL TYPE
    60. | 6.60 MALAYSIA MARKET ANALYSIS BY END USER
    61. | 6.61 THAILAND MARKET ANALYSIS BY PRODUCT TYPE
    62. | 6.62 THAILAND MARKET ANALYSIS BY TECHNOLOGY
    63. | 6.63 THAILAND MARKET ANALYSIS BY ANIMAL TYPE
    64. | 6.64 THAILAND MARKET ANALYSIS BY END USER
    65. | 6.65 INDONESIA MARKET ANALYSIS BY PRODUCT TYPE
    66. | 6.66 INDONESIA MARKET ANALYSIS BY TECHNOLOGY
    67. | 6.67 INDONESIA MARKET ANALYSIS BY ANIMAL TYPE
    68. | 6.68 INDONESIA MARKET ANALYSIS BY END USER
    69. | 6.69 REST OF APAC MARKET ANALYSIS BY PRODUCT TYPE
    70. | 6.70 REST OF APAC MARKET ANALYSIS BY TECHNOLOGY
    71. | 6.71 REST OF APAC MARKET ANALYSIS BY ANIMAL TYPE
    72. | 6.72 REST OF APAC MARKET ANALYSIS BY END USER
    73. | 6.73 SOUTH AMERICA MARKET ANALYSIS
    74. | 6.74 BRAZIL MARKET ANALYSIS BY PRODUCT TYPE
    75. | 6.75 BRAZIL MARKET ANALYSIS BY TECHNOLOGY
    76. | 6.76 BRAZIL MARKET ANALYSIS BY ANIMAL TYPE
    77. | 6.77 BRAZIL MARKET ANALYSIS BY END USER
    78. | 6.78 MEXICO MARKET ANALYSIS BY PRODUCT TYPE
    79. | 6.79 MEXICO MARKET ANALYSIS BY TECHNOLOGY
    80. | 6.80 MEXICO MARKET ANALYSIS BY ANIMAL TYPE
    81. | 6.81 MEXICO MARKET ANALYSIS BY END USER
    82. | 6.82 ARGENTINA MARKET ANALYSIS BY PRODUCT TYPE
    83. | 6.83 ARGENTINA MARKET ANALYSIS BY TECHNOLOGY
    84. | 6.84 ARGENTINA MARKET ANALYSIS BY ANIMAL TYPE
    85. | 6.85 ARGENTINA MARKET ANALYSIS BY END USER
    86. | 6.86 REST OF SOUTH AMERICA MARKET ANALYSIS BY PRODUCT TYPE
    87. | 6.87 REST OF SOUTH AMERICA MARKET ANALYSIS BY TECHNOLOGY
    88. | 6.88 REST OF SOUTH AMERICA MARKET ANALYSIS BY ANIMAL TYPE
    89. | 6.89 REST OF SOUTH AMERICA MARKET ANALYSIS BY END USER
    90. | 6.90 MEA MARKET ANALYSIS
    91. | 6.91 GCC COUNTRIES MARKET ANALYSIS BY PRODUCT TYPE
    92. | 6.92 GCC COUNTRIES MARKET ANALYSIS BY TECHNOLOGY
    93. | 6.93 GCC COUNTRIES MARKET ANALYSIS BY ANIMAL TYPE
    94. | 6.94 GCC COUNTRIES MARKET ANALYSIS BY END USER
    95. | 6.95 SOUTH AFRICA MARKET ANALYSIS BY PRODUCT TYPE
    96. | 6.96 SOUTH AFRICA MARKET ANALYSIS BY TECHNOLOGY
    97. | 6.97 SOUTH AFRICA MARKET ANALYSIS BY ANIMAL TYPE
    98. | 6.98 SOUTH AFRICA MARKET ANALYSIS BY END USER
    99. | 6.99 REST OF MEA MARKET ANALYSIS BY PRODUCT TYPE
    100. | 6.100 REST OF MEA MARKET ANALYSIS BY TECHNOLOGY
    101. | 6.101 REST OF MEA MARKET ANALYSIS BY ANIMAL TYPE
    102. | 6.102 REST OF MEA MARKET ANALYSIS BY END USER
    103. | 6.103 KEY BUYING CRITERIA OF HEALTHCARE
    104. | 6.104 RESEARCH PROCESS OF MRFR
    105. | 6.105 DRO ANALYSIS OF HEALTHCARE
    106. | 6.106 DRIVERS IMPACT ANALYSIS: HEALTHCARE
    107. | 6.107 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
    108. | 6.108 SUPPLY / VALUE CHAIN: HEALTHCARE
    109. | 6.109 HEALTHCARE, BY PRODUCT TYPE, 2024 (% SHARE)
    110. | 6.110 HEALTHCARE, BY PRODUCT TYPE, 2024 TO 2035 (USD Billion)
    111. | 6.111 HEALTHCARE, BY TECHNOLOGY, 2024 (% SHARE)
    112. | 6.112 HEALTHCARE, BY TECHNOLOGY, 2024 TO 2035 (USD Billion)
    113. | 6.113 HEALTHCARE, BY ANIMAL TYPE, 2024 (% SHARE)
    114. | 6.114 HEALTHCARE, BY ANIMAL TYPE, 2024 TO 2035 (USD Billion)
    115. | 6.115 HEALTHCARE, BY END USER, 2024 (% SHARE)
    116. | 6.116 HEALTHCARE, BY END USER, 2024 TO 2035 (USD Billion)
    117. | 6.117 BENCHMARKING OF MAJOR COMPETITORS
  7. LIST OF TABLES
    1. | 7.1 LIST OF ASSUMPTIONS
    2. | | 7.1.1
    3. | 7.2 North America MARKET SIZE ESTIMATES; FORECAST
    4. | | 7.2.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    5. | | 7.2.2 BY TECHNOLOGY, 2025-2035 (USD Billion)
    6. | | 7.2.3 BY ANIMAL TYPE, 2025-2035 (USD Billion)
    7. | | 7.2.4 BY END USER, 2025-2035 (USD Billion)
    8. | 7.3 US MARKET SIZE ESTIMATES; FORECAST
    9. | | 7.3.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    10. | | 7.3.2 BY TECHNOLOGY, 2025-2035 (USD Billion)
    11. | | 7.3.3 BY ANIMAL TYPE, 2025-2035 (USD Billion)
    12. | | 7.3.4 BY END USER, 2025-2035 (USD Billion)
    13. | 7.4 Canada MARKET SIZE ESTIMATES; FORECAST
    14. | | 7.4.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    15. | | 7.4.2 BY TECHNOLOGY, 2025-2035 (USD Billion)
    16. | | 7.4.3 BY ANIMAL TYPE, 2025-2035 (USD Billion)
    17. | | 7.4.4 BY END USER, 2025-2035 (USD Billion)
    18. | 7.5 Europe MARKET SIZE ESTIMATES; FORECAST
    19. | | 7.5.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    20. | | 7.5.2 BY TECHNOLOGY, 2025-2035 (USD Billion)
    21. | | 7.5.3 BY ANIMAL TYPE, 2025-2035 (USD Billion)
    22. | | 7.5.4 BY END USER, 2025-2035 (USD Billion)
    23. | 7.6 Germany MARKET SIZE ESTIMATES; FORECAST
    24. | | 7.6.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    25. | | 7.6.2 BY TECHNOLOGY, 2025-2035 (USD Billion)
    26. | | 7.6.3 BY ANIMAL TYPE, 2025-2035 (USD Billion)
    27. | | 7.6.4 BY END USER, 2025-2035 (USD Billion)
    28. | 7.7 UK MARKET SIZE ESTIMATES; FORECAST
    29. | | 7.7.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    30. | | 7.7.2 BY TECHNOLOGY, 2025-2035 (USD Billion)
    31. | | 7.7.3 BY ANIMAL TYPE, 2025-2035 (USD Billion)
    32. | | 7.7.4 BY END USER, 2025-2035 (USD Billion)
    33. | 7.8 France MARKET SIZE ESTIMATES; FORECAST
    34. | | 7.8.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    35. | | 7.8.2 BY TECHNOLOGY, 2025-2035 (USD Billion)
    36. | | 7.8.3 BY ANIMAL TYPE, 2025-2035 (USD Billion)
    37. | | 7.8.4 BY END USER, 2025-2035 (USD Billion)
    38. | 7.9 Russia MARKET SIZE ESTIMATES; FORECAST
    39. | | 7.9.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    40. | | 7.9.2 BY TECHNOLOGY, 2025-2035 (USD Billion)
    41. | | 7.9.3 BY ANIMAL TYPE, 2025-2035 (USD Billion)
    42. | | 7.9.4 BY END USER, 2025-2035 (USD Billion)
    43. | 7.10 Italy MARKET SIZE ESTIMATES; FORECAST
    44. | | 7.10.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    45. | | 7.10.2 BY TECHNOLOGY, 2025-2035 (USD Billion)
    46. | | 7.10.3 BY ANIMAL TYPE, 2025-2035 (USD Billion)
    47. | | 7.10.4 BY END USER, 2025-2035 (USD Billion)
    48. | 7.11 Spain MARKET SIZE ESTIMATES; FORECAST
    49. | | 7.11.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    50. | | 7.11.2 BY TECHNOLOGY, 2025-2035 (USD Billion)
    51. | | 7.11.3 BY ANIMAL TYPE, 2025-2035 (USD Billion)
    52. | | 7.11.4 BY END USER, 2025-2035 (USD Billion)
    53. | 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
    54. | | 7.12.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    55. | | 7.12.2 BY TECHNOLOGY, 2025-2035 (USD Billion)
    56. | | 7.12.3 BY ANIMAL TYPE, 2025-2035 (USD Billion)
    57. | | 7.12.4 BY END USER, 2025-2035 (USD Billion)
    58. | 7.13 APAC MARKET SIZE ESTIMATES; FORECAST
    59. | | 7.13.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    60. | | 7.13.2 BY TECHNOLOGY, 2025-2035 (USD Billion)
    61. | | 7.13.3 BY ANIMAL TYPE, 2025-2035 (USD Billion)
    62. | | 7.13.4 BY END USER, 2025-2035 (USD Billion)
    63. | 7.14 China MARKET SIZE ESTIMATES; FORECAST
    64. | | 7.14.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    65. | | 7.14.2 BY TECHNOLOGY, 2025-2035 (USD Billion)
    66. | | 7.14.3 BY ANIMAL TYPE, 2025-2035 (USD Billion)
    67. | | 7.14.4 BY END USER, 2025-2035 (USD Billion)
    68. | 7.15 India MARKET SIZE ESTIMATES; FORECAST
    69. | | 7.15.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    70. | | 7.15.2 BY TECHNOLOGY, 2025-2035 (USD Billion)
    71. | | 7.15.3 BY ANIMAL TYPE, 2025-2035 (USD Billion)
    72. | | 7.15.4 BY END USER, 2025-2035 (USD Billion)
    73. | 7.16 Japan MARKET SIZE ESTIMATES; FORECAST
    74. | | 7.16.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    75. | | 7.16.2 BY TECHNOLOGY, 2025-2035 (USD Billion)
    76. | | 7.16.3 BY ANIMAL TYPE, 2025-2035 (USD Billion)
    77. | | 7.16.4 BY END USER, 2025-2035 (USD Billion)
    78. | 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
    79. | | 7.17.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    80. | | 7.17.2 BY TECHNOLOGY, 2025-2035 (USD Billion)
    81. | | 7.17.3 BY ANIMAL TYPE, 2025-2035 (USD Billion)
    82. | | 7.17.4 BY END USER, 2025-2035 (USD Billion)
    83. | 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
    84. | | 7.18.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    85. | | 7.18.2 BY TECHNOLOGY, 2025-2035 (USD Billion)
    86. | | 7.18.3 BY ANIMAL TYPE, 2025-2035 (USD Billion)
    87. | | 7.18.4 BY END USER, 2025-2035 (USD Billion)
    88. | 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
    89. | | 7.19.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    90. | | 7.19.2 BY TECHNOLOGY, 2025-2035 (USD Billion)
    91. | | 7.19.3 BY ANIMAL TYPE, 2025-2035 (USD Billion)
    92. | | 7.19.4 BY END USER, 2025-2035 (USD Billion)
    93. | 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
    94. | | 7.20.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    95. | | 7.20.2 BY TECHNOLOGY, 2025-2035 (USD Billion)
    96. | | 7.20.3 BY ANIMAL TYPE, 2025-2035 (USD Billion)
    97. | | 7.20.4 BY END USER, 2025-2035 (USD Billion)
    98. | 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
    99. | | 7.21.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    100. | | 7.21.2 BY TECHNOLOGY, 2025-2035 (USD Billion)
    101. | | 7.21.3 BY ANIMAL TYPE, 2025-2035 (USD Billion)
    102. | | 7.21.4 BY END USER, 2025-2035 (USD Billion)
    103. | 7.22 South America MARKET SIZE ESTIMATES; FORECAST
    104. | | 7.22.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    105. | | 7.22.2 BY TECHNOLOGY, 2025-2035 (USD Billion)
    106. | | 7.22.3 BY ANIMAL TYPE, 2025-2035 (USD Billion)
    107. | | 7.22.4 BY END USER, 2025-2035 (USD Billion)
    108. | 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
    109. | | 7.23.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    110. | | 7.23.2 BY TECHNOLOGY, 2025-2035 (USD Billion)
    111. | | 7.23.3 BY ANIMAL TYPE, 2025-2035 (USD Billion)
    112. | | 7.23.4 BY END USER, 2025-2035 (USD Billion)
    113. | 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
    114. | | 7.24.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    115. | | 7.24.2 BY TECHNOLOGY, 2025-2035 (USD Billion)
    116. | | 7.24.3 BY ANIMAL TYPE, 2025-2035 (USD Billion)
    117. | | 7.24.4 BY END USER, 2025-2035 (USD Billion)
    118. | 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
    119. | | 7.25.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    120. | | 7.25.2 BY TECHNOLOGY, 2025-2035 (USD Billion)
    121. | | 7.25.3 BY ANIMAL TYPE, 2025-2035 (USD Billion)
    122. | | 7.25.4 BY END USER, 2025-2035 (USD Billion)
    123. | 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
    124. | | 7.26.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    125. | | 7.26.2 BY TECHNOLOGY, 2025-2035 (USD Billion)
    126. | | 7.26.3 BY ANIMAL TYPE, 2025-2035 (USD Billion)
    127. | | 7.26.4 BY END USER, 2025-2035 (USD Billion)
    128. | 7.27 MEA MARKET SIZE ESTIMATES; FORECAST
    129. | | 7.27.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    130. | | 7.27.2 BY TECHNOLOGY, 2025-2035 (USD Billion)
    131. | | 7.27.3 BY ANIMAL TYPE, 2025-2035 (USD Billion)
    132. | | 7.27.4 BY END USER, 2025-2035 (USD Billion)
    133. | 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
    134. | | 7.28.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    135. | | 7.28.2 BY TECHNOLOGY, 2025-2035 (USD Billion)
    136. | | 7.28.3 BY ANIMAL TYPE, 2025-2035 (USD Billion)
    137. | | 7.28.4 BY END USER, 2025-2035 (USD Billion)
    138. | 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
    139. | | 7.29.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    140. | | 7.29.2 BY TECHNOLOGY, 2025-2035 (USD Billion)
    141. | | 7.29.3 BY ANIMAL TYPE, 2025-2035 (USD Billion)
    142. | | 7.29.4 BY END USER, 2025-2035 (USD Billion)
    143. | 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
    144. | | 7.30.1 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    145. | | 7.30.2 BY TECHNOLOGY, 2025-2035 (USD Billion)
    146. | | 7.30.3 BY ANIMAL TYPE, 2025-2035 (USD Billion)
    147. | | 7.30.4 BY END USER, 2025-2035 (USD Billion)
    148. | 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
    149. | | 7.31.1
    150. | 7.32 ACQUISITION/PARTNERSHIP
    151. | | 7.32.1

Healthcare Market Segmentation

Healthcare By Product Type (USD Billion, 2025-2035)

  • Immunoassays
  • Sampling Devices
  • Molecular Diagnostics
  • Hematology Analyzers

Healthcare By Technology (USD Billion, 2025-2035)

  • Biochemical Analysis
  • Microbiology Testing
  • Genetic Testing

Healthcare By Animal Type (USD Billion, 2025-2035)

  • Companion Animals
  • Livestock
  • Zoo Animals

Healthcare By End User (USD Billion, 2025-2035)

  • Veterinary Clinics
  • Research Laboratories
  • Animal Hospitals
Infographic

Free Sample Request

Kindly complete the form below to receive a free sample of this Report

Get Free Sample

Related Reports

Regional Reports
Country Reports

Customer Strories

Customer Stories
Case Study Cover Image
Case Study
Aerospace & Defense
Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization ✓ ✓ ✓
Direct Access to Analyst ✓ ✓ ✓
Deliverable Format ✓ ✓ ✓
Platform Access ✗ ✗ ✓
Discount on Next Purchase 10% 15% 15%
Printable Versions ✗ ✗ ✓